[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Redeye_ Redeye
Redeye posts on X about $geno, $infra, strong, $bonex the most. They currently have XXXXXX followers and XX posts still getting attention that total XX engagements in the last XX hours.
Engagements: XX #
- X Week XXXXX -XX%
- X Month XXXXXX -XX%
- X Months XXXXXXX -XX%
- X Year XXXXXXXXX -XXXX%
Mentions: XX #
- X Week XX -XX%
- X Month XXX -XX%
- X Months XXXXX +73%
- X Year XXXXX +50%
Followers: XXXXXX #
- X Week XXXXXX no change
- X Month XXXXXX -XXXX%
- X Months XXXXXX -XXXX%
- X Year XXXXXX -XXXX%
CreatorRank: undefined #
Social Influence
Social category influence cryptocurrencies XXXXX% finance XXXX%
Social topic influence $geno #2, $infra #11, strong 6.45%, $bonex 3.23%, $ferro 3.23%, $indt 3.23%, $mob 3.23%, mob 3.23%, $cinpha 3.23%, business XXXX%
Top accounts mentioned or mentioned by @cryptoreview24 @aiagentmaya
Top assets mentioned GenomeFi (GENO) Bware (INFRA) MobileCoin (MOB) Acute Angle Cloud (AAC)
Top Social Posts
Top posts by engagements in the last XX hours
"Redeye views Genovis Q3 as softer than anticipated. $GENO"
X Link 2025-11-07T08:26Z 14.5K followers, 1051 engagements
"Redeye comments on BONESUPPORT announcing that the pathway for CERAMENT V would be transferred from a 510k to a De Novo process following discussions with the FDA. $BONEX"
X Link 2025-12-02T12:14Z 14.5K followers, 1845 engagements
"Redeye initiates coverage of Ferroamp a greentech company offering a modular hardware and software platform for smart energy control in buildings. $FERRO"
X Link 2025-11-26T07:14Z 14.5K followers, XXX engagements
"Redeye comments on Genovis decision to acquire the remaining XX% of SEQURNA viewing it as a logical synergistic move that leverages its growing net cash and adds exposure to the sizable and growing genomics market. $GENO"
X Link 2025-07-02T09:46Z 14.5K followers, 1484 engagements
"Redeye updates its estimates and valuation after Indutrades Q3 2025 report. $INDT"
X Link 2025-10-21T13:25Z 14.5K followers, XXX engagements
"Redeye views the Q3 report as solid with sales slightly ahead of expectations and tighter cost control than anticipated. $MOB"
X Link 2025-11-14T07:37Z 14.5K followers, XXX engagements
"Redeye leaves a comment following Cinclus announcement that its lead candidate linaprazan glurate has been included on Chinas 2025 National Reimbursement Drug List. $CINPHA"
X Link 2025-12-08T10:37Z 14.5K followers, XXX engagements
"Redeye notes an interesting press release from Genovis confirming a SEK11m order from a global pharmaceutical company. $GENO"
X Link 2025-10-20T05:00Z 14.5K followers, 1323 engagements
"Redeye notes that InfraComs Q3 2025 report aligned with net sales estimates but EBITDA was weighed on by higher-than-anticipated operating expenses (OPEX). $INFRA"
X Link 2025-11-11T08:19Z 14.5K followers, XXX engagements
"Redeye notes that InfraCom's Q3 2025 net sales met expectations but EBITDA was impacted by operating expenses X% above projections. $INFRA"
X Link 2025-11-12T07:33Z 14.5K followers, XXX engagements
"Redeye views Genovis' soft Q3 as a bump on the road ahead of a strong Q4. $GENO"
X Link 2025-11-12T07:35Z 14.5K followers, 1194 engagements
"Redeye initiates coverage of AAC Clyde Space a leading smallsat provider with a strong position within satellite components and missions now growing into the Data & Services business. $AAC"
X Link 2025-12-05T07:51Z 14.5K followers, XXX engagements
"Redeye updates its estimates and valuation after Surgical Sciences capital markets day. $SUS"
X Link 2025-12-09T07:25Z 14.5K followers, XXX engagements